Professor in Microbiology at Lund University, Godaly has >20 years’ experience in the field of infection and intensive care medicine. She has a background with clinical trials on life-supporting drug candidates for critically ill patients through her six years of experience in the pharmaceutical industry with focus on clinical trials at Gambro Lundia AB. Beginning with research on innate defences, vaccine and diagnostic studies, she is now working on alternative treatment for tuberculosis.